Insights

Gathering insights about Eidos Therapeutics…

Similar companies to Eidos Therapeutics

Eidos Therapeutics Tech Stack

Eidos Therapeutics uses 8 technology products and services including SAS/STAT, Google Analytics, Cloudflare, and more. Explore Eidos Therapeutics's tech stack below.

SAS/STAT
Advanced Analytics And Data Science
Google Analytics
Analytics
Cloudflare
Content Management System
Salesforce
Customer Relationship Management
Microsoft Word
Editors
Twitter Emoji (Twemoji)
Font Scripts
Open Graph
Miscellaneous
Zoom
Web Conferencing

Media & News

Eidos Therapeutics's Email Address Formats

Eidos Therapeutics uses at least 1 format(s):

Eidos Therapeutics Email Formats	Example	Percentage
FLast@eidostx.com	JDoe@eidostx.com	45%
First.Last@eidostx.com	John.Doe@eidostx.com	8%
Last@eidostx.com	Doe@eidostx.com	2%
FLast@eidostx.com	JDoe@eidostx.com	45%

Frequently Asked Questions

Where is Eidos Therapeutics's headquarters located?

Eidos Therapeutics's main headquarters is located at 101 Montgomery St San Francisco, California US. The company has employees across 2 continents, including North AmericaEurope.

What is Eidos Therapeutics's phone number?

You can contact Eidos Therapeutics's main corporate office by phone at

+1-415-887-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Eidos Therapeutics's stock symbol?

Eidos Therapeutics is a publicly traded company; the company's stock symbol is EIDX.

What is Eidos Therapeutics's official website and social media links?

Eidos Therapeutics's official website is eidostx.com and has social profiles on LinkedIn.

How much revenue does Eidos Therapeutics generate?

As of October 2023, Eidos Therapeutics's annual revenue reached $7.5M.

What is Eidos Therapeutics's SIC code NAICS code?

Eidos Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Eidos Therapeutics have currently?

As of October 2023, Eidos Therapeutics has approximately 52 employees across 2 continents, including North AmericaEurope. Key team members include Chief Executive Officer: N. K.Chief Finance Officer: C. S.Chief Business Officer: C. T.. Explore Eidos Therapeutics's employee directory with LeadIQ.

What industry does Eidos Therapeutics belong to?

Eidos Therapeutics operates in the Biotechnology Research industry.

What technology does Eidos Therapeutics use?

Eidos Therapeutics's tech stack includes SAS/STATGoogle AnalyticsCloudflareSalesforceMicrosoft WordTwitter Emoji (Twemoji)Open GraphZoom.

What is Eidos Therapeutics's email format?

Eidos Therapeutics's email format typically follows the pattern of . Find more Eidos Therapeutics email formats with LeadIQ.

How much funding has Eidos Therapeutics raised to date?

As of October 2023, Eidos Therapeutics has raised $64M in funding. The last funding round occurred on Apr 05, 2018 for $64M.

When was Eidos Therapeutics founded?

Eidos Therapeutics was founded in 2016.

Eidos Therapeutics

Biotechnology ResearchCalifornia, United States51-200 Employees

Eidos Therapeutics, a subsidiary of BridgeBio Pharma, is developing AG10 as a targeted therapeutic for transthyretin amyloidosis. The company’s singular mission is to improve and prolong the lives of patients suffering from this disease.

Launched in 2016 after years of research supported by Stanford’s SPARK program, Eidos is led by a team of veteran biotechnology executives. Together with patients and physicians, the company aims to bring a safe, effective treatment to market as quickly as possible.

Company Overview

Headquarters: 101 Montgomery St San Francisco, California US
Phone number: ✕
Access Insights for Eidos Therapeutics and Millions of Other Companies
Sign up for full access to Eidos Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-415-887-****
Website: eidostx.com
SIC Code: 8733 - Noncommercial Research Organizations
Stock Symbol: EIDX
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2016
Employees: 51-200

Media & News

Funding & Financials

$64M
Eidos Therapeutics has raised a total of $64M of funding over 1 rounds. Their latest funding round was raised on Apr 05, 2018 in the amount of $64M.
$10M
Eidos Therapeutics's revenue is in the range of $10M

Funding & Financials

$64M
Eidos Therapeutics has raised a total of $64M of funding over 1 rounds. Their latest funding round was raised on Apr 05, 2018 in the amount of $64M.
$10M
Eidos Therapeutics's revenue is in the range of $10M

Company Leadership

N. K.
Chief Executive Officer
✕
Access Insights for Eidos Therapeutics and Millions of Other Companies
Sign up for full access to Eidos Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Eidos Therapeutics and Millions of Other Companies
Sign up for full access to Eidos Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
C. S.
Chief Finance Officer
✕
Access Insights for Eidos Therapeutics and Millions of Other Companies
Sign up for full access to Eidos Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Eidos Therapeutics and Millions of Other Companies
Sign up for full access to Eidos Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
C. T.
Chief Business Officer
✕
Access Insights for Eidos Therapeutics and Millions of Other Companies
Sign up for full access to Eidos Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Eidos Therapeutics and Millions of Other Companies
Sign up for full access to Eidos Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. M.
Vice President Clinical Operations
✕
Access Insights for Eidos Therapeutics and Millions of Other Companies
Sign up for full access to Eidos Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Eidos Therapeutics and Millions of Other Companies
Sign up for full access to Eidos Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
D. S. S.
Vice President & Head Of Regulatory
✕
Access Insights for Eidos Therapeutics and Millions of Other Companies
Sign up for full access to Eidos Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Eidos Therapeutics and Millions of Other Companies
Sign up for full access to Eidos Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

C. I.
Senior Vice President - Clinical Development & Medical Affairs
✕
Access Insights for Eidos Therapeutics and Millions of Other Companies
Sign up for full access to Eidos Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Eidos Therapeutics and Millions of Other Companies
Sign up for full access to Eidos Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
D. S. S.
Vice President & Head Of Regulatory
✕
Access Insights for Eidos Therapeutics and Millions of Other Companies
Sign up for full access to Eidos Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Eidos Therapeutics and Millions of Other Companies
Sign up for full access to Eidos Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. H.
Vice President, Quality And Compliance
✕
Access Insights for Eidos Therapeutics and Millions of Other Companies
Sign up for full access to Eidos Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Eidos Therapeutics and Millions of Other Companies
Sign up for full access to Eidos Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. T.
Vice President Of Program Management
✕
Access Insights for Eidos Therapeutics and Millions of Other Companies
Sign up for full access to Eidos Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Eidos Therapeutics and Millions of Other Companies
Sign up for full access to Eidos Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
L. K.
Senior Vice President, Clinical Development
✕
Access Insights for Eidos Therapeutics and Millions of Other Companies
Sign up for full access to Eidos Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Eidos Therapeutics and Millions of Other Companies
Sign up for full access to Eidos Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to Eidos Therapeutics

Moderna

Retrophin

Vertex Pharmaceuticals

Biogen

Sarepta Therapeutics

Alnylam Pharmaceuticals

Akcea Therapeutics

Eidos Therapeutics Tech Stack

Media & News

GlaxoSmithKline acquires Eidostx for $0.

BridgeBio Inc. acquired Eidostx on Jan 1st '19.

BridgeBio Inc. merged with Eidostx on Jan 1st '21.

BridgeBio Inc. partnered with Eidostx on Oct 5th '20.

Eidostx goes public.

Eidostx partners with Association of Black Cardiologists, Inc..

Eidostx partners with Alexion Pharmaceuticals, Inc..

Eidos Therapeutics's Email Address Formats

Frequently Asked Questions

Where is Eidos Therapeutics's headquarters located?

What is Eidos Therapeutics's phone number?

What is Eidos Therapeutics's stock symbol?

What is Eidos Therapeutics's official website and social media links?

How much revenue does Eidos Therapeutics generate?

What is Eidos Therapeutics's SIC code NAICS code?

How many employees does Eidos Therapeutics have currently?

What industry does Eidos Therapeutics belong to?

What technology does Eidos Therapeutics use?

What is Eidos Therapeutics's email format?

How much funding has Eidos Therapeutics raised to date?

When was Eidos Therapeutics founded?

Eidos Therapeutics

Company Overview

Media & News

GlaxoSmithKline acquires Eidostx for $0.

BridgeBio Inc. acquired Eidostx on Jan 1st '19.

BridgeBio Inc. merged with Eidostx on Jan 1st '21.

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?